60 Degrees Pharmaceuticals Inc. (SXTP)
(Delayed Data from NSDQ)
$1.35 USD
-0.04 (-2.54%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $1.34 -0.01 (-0.37%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth F Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, 60 Degrees Pharmaceuticals Inc. has a market cap of $2.03M, which represents its share price of $1.38 multiplied by its outstanding shares number of 1.47M. As a small-cap company, SXTP's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
SXTP 1.35 -0.04(-2.54%)
Will SXTP be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SXTP based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SXTP
Ardelyx (ARDX) Reports Q2 Loss, Tops Revenue Estimates
Harrow (HROW) Reports Q1 Loss, Lags Revenue Estimates
SXTP: What are Zacks experts saying now?
Zacks Private Portfolio Services
60 Degrees Pharmaceuticals Inc. (SXTP) Reports Q3 Loss, Misses Revenue Estimates
VAXART, INC. (VXRT) Reports Q3 Loss, Tops Revenue Estimates
OptiNose (OPTN) Reports Break-Even Earnings for Q3
Other News for SXTP
60 Degrees Pharmaceuticals (SXTP) Partners with Tulane University for Lyme Disease Research | ...
60 Degrees Pharmaceuticals and Tulane University Sign Research Agreement to Study Tafenoquine ...
60 Degrees Pharmaceuticals, Tulane University sign research agreement
12 Health Care Stocks Moving In Tuesday's Intraday Session
60 Degrees Pharmaceuticals (SXTP) Announces Public Offering Details